Clinical Research Study For Nash

Learn about the NASHGEN-2 clinical study

Living with NASH? You are not alone.

Living with non-alcoholic steatohepatitis (NASH) may feel overwhelming, and you may feel that you have enough to do without committing to a clinical study. However, you may play a key role in helping to develop treatments that are being studied to help advance our medical knowledge of NASH. Every treatment that exists today is available because of study participants who actively took part in research.

Clinical studies are essential to investigating potential treatments and are not possible without the people who take part. Everyone involved in this clinical study plays an important role in increasing our understanding of NASH, which may help others in the future with this condition.

This website provides information about a clinical study, NASHGEN-2, for people with NASH. NASH is a form of non-alcoholic fatty liver disease (NAFLD) that occurs when fat accumulates in liver cells. When fat accumulates in your liver, your body’s response through your natural defense system – the immune system – results in inflammation, which causes damage to nearby cells. Risk factors for developing NASH include diabetes, obesity, high blood pressure, and possibly other factors such as a person’s genetics (the patterns of DNA that control how their bodies work). The aim of this study is to see the effect of the investigational treatment on reducing liver scarring in study participants who have certain genetic risk factors for NASH.

Learn more about NASHGEN-2, and see if it may be an option for you or someone you know.